Medicare Enrolled
Dr. Samah Mohiuddin, MD
Neurology · Watertown, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mohiuddin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohiuddin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mohiuddin
Dr. Samah Mohiuddin is a neurology specialist in Watertown, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Mohiuddin performed 1,905 Medicare services across 1,157 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mohiuddin received a total of $4,266 from 41 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mohiuddin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 19% volume in NY
$4,266 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,905
Medicare services
Top 19% in NY for neurology
1,157
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
706 | $84 | $307 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
243 | $95 | $450 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
125 | $61 | $300 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
125 | $89 | $555 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 113 | $51 | $898 |
| Facial nerve injection with anesthetic and/or steroid An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve. |
108 | $111 | $1,062 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
105 | $39 | $955 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
86 | $72 | $363 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $116 | $358 |
| New patient office visit, complex (60-74 min) | 38 | $138 | $469 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
34 | $284 | $2,200 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
29 | $212 | $1,621 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
28 | $30 | $62 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $129 | $424 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
21 | $61 | $276 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $127 | $647 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 13 | $179 | $600 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $99 | $452 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,266
Total received (2018-2024)
Avg $609/year across 7 years
Top 35% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
209
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,976 (69.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,289 (30.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$803
2023
$234
2022
$145
2021
$19
2020
$265
2019
$1,055
2018
$1,745
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$260
ABBVIE INC.
$187
PFIZER INC.
$51
Eisai Inc.
$47
Novartis Pharmaceuticals Corporation
$44
Genentech USA, Inc.
$43
Biogen, Inc.
$41
Neurelis, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Lilly USA, LLC
$25
Alnylam Pharmaceuticals Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
HARMONY BIOSCIENCES LLC
$17
Top 3 companies account for 62.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,513
Genentech USA, Inc.
$332
Novartis Pharmaceuticals Corporation
$233
ABBVIE INC.
$204
Supernus Pharmaceuticals, Inc.
$200
Biogen, Inc.
$193
Lilly USA, LLC
$161
Sunovion Pharmaceuticals Inc.
$149
UCB, Inc.
$133
Allergan Inc.
$109
GENZYME CORPORATION
$87
EMD Serono, Inc.
$84
Amgen Inc.
$72
LivaNova USA, Inc.
$64
PFIZER INC.
$63
Mallinckrodt LLC
$62
Mallinckrodt Enterprises LLC
$50
Abbott Laboratories
$49
Avanir Pharmaceuticals, Inc.
$48
Eisai Inc.
$47
Merz North America, Inc.
$39
CSL Behring
$35
Neurelis, Inc.
$27
Strongbridge US INC.
$27
Otsuka America Pharmaceutical, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$21
Alexion Pharmaceuticals, Inc.
$19
AbbVie Inc.
$19
Lundbeck LLC
$19
Alnylam Pharmaceuticals Inc.
$18
Impax Laboratories, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
HARMONY BIOSCIENCES LLC
$17
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Merck Sharp & Dohme Corporation
$15
AbbVie, Inc.
$14
Celgene Corporation
$14
Neurocrine Biosciences, Inc.
$14
Jazz Pharmaceuticals Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$14
ACADIA Pharmaceuticals Inc
$11
Top 3 companies account for 48.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · COPAXONE · EMGALITY · GILENYA · HYQVIA · Hizentra · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · LEMTRADA · LYRICA · Leqembi · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · ONFI · ONPATTRO · OXTELLAR XR · Ocrevus · QULIPTA · RADICAVA · RYTARY · Rebif · SOLIRIS · SPECTRA WAVEWRITER (REFURBISHED) · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VNS Therapy · WAKIX · XEOMIN · XYREM · Xyrem · ZEPOSIA · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
4
Per 100K population
3.4
County median income
$64,978
Nearest hospital
SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mohiuddin is a clinical cardiology specialist, with above-average Medicare volume (top 19% in NY), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mohiuddin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mohiuddin performed 706 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohiuddin receive payments from pharmaceutical companies?
Yes. Dr. Mohiuddin received a total of $4,266 from 41 companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohiuddin's costs compare to other neurologists in Watertown?
Dr. Mohiuddin's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohiuddin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Watertown
Browse neurologists in Watertown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology